← Back to Search

Behavioural Intervention

Eye Gaze Technology for Cortical Visual Impairment

N/A
Recruiting
Led By Tammy Bruegger
Research Sponsored by Rockhurst University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with Cortical/Cerebral Visual Impairment by Physician
2-10 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up test given at baseline.
Awards & highlights

Study Summary

This trial tests if using eye gaze technology with graded visual activities can improve visual abilities & occupational performance in children with CVI.

Who is the study for?
This trial is for children aged 2-10 with cortical visual impairment, where a parent or caregiver is available for interviews. It's not suitable for those with only ocular vision issues or without a caregiver to participate in the study process.Check my eligibility
What is being tested?
The study tests if eye gaze technology can improve visual abilities and daily activities in kids with visual impairments. They'll use special software and play graded visual games for 20 minutes daily over four weeks, while their progress is monitored.See study design
What are the potential side effects?
There are no specific side effects mentioned for using eye gaze technology in this trial; however, it involves close observation of the child's reactions and adjustments to ensure comfort and safety during participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a vision impairment by a doctor.
Select...
I am between 2 and 10 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measure change from baseline and after 4 weeks of intervention.
This trial's timeline: 3 weeks for screening, Varies for treatment, and measure change from baseline and after 4 weeks of intervention. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Canadian Occupational Performance Measurement (COPM)
Cortical Visual Impairment Range (CVI)
Eye Gaze Technology Software Scoring: Insight Software
Other outcome measures
Sensory Processing Checklist for Children with Visual Impairment (SPCCVI)
Sensory Profile-Short Form (SPSF)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Eye gaze technology interventionExperimental Treatment1 Intervention
Participants will use eye gaze technology and software activities as an intervention to improve visual abilities.

Find a Location

Who is running the clinical trial?

Rockhurst UniversityLead Sponsor
2 Previous Clinical Trials
50 Total Patients Enrolled
1 Trials studying Cerebral Palsy
35 Patients Enrolled for Cerebral Palsy
Tammy BrueggerPrincipal InvestigatorRockhurst University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for participants in this research?

"Affirmative. According to the records posted on clinicaltrials.gov, this medical study is actively seeking participants and has been open since February 1st 2023 with an update as recent as October 2nd of the same year. Aspiring candidates must be aware that only 10 patients can join from one single site."

Answered by AI

To what extent is this study populated with participants?

"Correct. According to clinicaltrials.gov, this medical experiment has been recruiting since February 1st 2023 and is still open for enrollment as of October 2nd 2023. 10 participants are needed at a single location."

Answered by AI

Do I meet the qualifications for this research project?

"A maximum of 10 individuals can join this trial, all of whom should display symptoms of cerebral palsy and be between 2-10 years old."

Answered by AI

Is the inclusion criteria for this study contingent upon a minimum age?

"This research has a very specific age bracket for participants – they must be between 2 and 10 years old. There are 175 studies available for those under the legal age of majority, and 59 trials that cater to patients over 65."

Answered by AI
~5 spots leftby Apr 2025